134 related articles for article (PubMed ID: 1106118)
1. Bioavailability studies on a buffered acetylsalicylic acid preparation.
Ekenved G; Elofsson R; Sölvell L
Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
[No Abstract] [Full Text] [Related]
2. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
3. The bioavailability of enteric-coated acetylsalicylic acid: a comparison with buffered ASA in rheumatoid arthritis II.
Canada AT; Little AH; Creighton EL
Curr Ther Res Clin Exp; 1976 May; 19(5):554-7. PubMed ID: 820521
[No Abstract] [Full Text] [Related]
4. Absorption, and effect on gastric mucosa, of buffered and non-buffered tablets of acetylsalicylic acid.
Linnoila M; Lehtola J
Int J Clin Pharmacol Biopharm; 1977 Feb; 15(2):61-4. PubMed ID: 885664
[TBL] [Abstract][Full Text] [Related]
5. [Absorption studies on salicylates. 1. Absorption of acetylsalicylic acid after oral application].
Pütter J; Bauer K
Arzneimittelforschung; 1970 Nov; 20(11):1718-20. PubMed ID: 5536978
[No Abstract] [Full Text] [Related]
6. The bioavailability of enteric-coated acetylsalicylic acid: a comparative study in reheumatoid arthritis, I.
Canada AT; Little AH
Curr Ther Res Clin Exp; 1975 Nov; 18(5):727-32. PubMed ID: 812651
[No Abstract] [Full Text] [Related]
7. [Comparative studies on the in vitro dissolution and bioavailability of various acetylsalicylic acid preparations].
Nieder M; Rasper J; Gielsdorf W; Russmann D; Jaeger H
Arzneimittelforschung; 1983; 33(3):439-45. PubMed ID: 6683520
[TBL] [Abstract][Full Text] [Related]
8. [Acetylsalicylic acid and gastrointestinal bleeding--a study of blood loss and absorption after intake of a gastric juice--resistant preparation].
Arvidsson B; Magnusson A; Magnusson B; Sölvell L
Lakartidningen; 1977 Nov; 74(46):4101-2. PubMed ID: 337007
[No Abstract] [Full Text] [Related]
9. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
Delporte JP; Jaminet F
J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
Viganò G; Garagiola U; Gaspari F
Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
[TBL] [Abstract][Full Text] [Related]
11. [Bioavailability of buffered acetylsalicylic acid].
Finzi GF; Riolo U; Ghini R
Arch Sci Med (Torino); 1981; 138(4):467-9. PubMed ID: 7340731
[No Abstract] [Full Text] [Related]
12. [The effect of the formulation of enterosoluble preparations on the physiologic dispensation of the active principle. Part 2: Effect of the elevation of disintegration time of coated tablets by augmentation of dentistry of coating on absorption characteristics of acetylsalicylic acid].
Delporte JP; Jaminet F
J Pharm Belg; 1976; 31(1):38-50. PubMed ID: 1255403
[No Abstract] [Full Text] [Related]
13. Bioavailability and tolerance studies on acetylsalicylic acid suppositories.
Borg KO; Ekenved G; Elofsson R; Sjögren J; Sölvell L
Acta Pharm Suec; 1975; 12(5-6):491-8. PubMed ID: 1217502
[No Abstract] [Full Text] [Related]
14. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
Arvidsson B; Magnusson B; Sölvell ; Magnusson A
Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
[TBL] [Abstract][Full Text] [Related]
15. [Preclinical and clinical pharmacokinetic study of orally administered effervescent acetylsalicylic acid tablets].
Dévay A; Uderszky J; Tanay J; Nyitrai T; Sátori E; Rácz I
Acta Pharm Hung; 1985 May; 55(3):114-8. PubMed ID: 4036626
[No Abstract] [Full Text] [Related]
16. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
[TBL] [Abstract][Full Text] [Related]
17. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
Stozek T
Pol J Pharmacol Pharm; 1975; 27(2):227-33. PubMed ID: 1153355
[TBL] [Abstract][Full Text] [Related]
18. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
Paton TW; Walker SE; Leung FY; Little AH
Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
[No Abstract] [Full Text] [Related]
19. Comparison of the bioavailability of aspirin tablets and suppositories.
Superstine SY; Superstine E; Penchas S
Isr J Med Sci; 1978 Feb; 14(2):292-4. PubMed ID: 649361
[No Abstract] [Full Text] [Related]
20. [Comparison of the pharmacokinetic behavior of Turivital, Acesal and Micristin].
Traeger A; Berlet G; Schröber R; Zaumseil J; Chemnitius KH
Pharmazie; 1984 Jun; 39(6):409-10. PubMed ID: 6435136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
